Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02180282 · ClinicalTrials.gov registry record · NA
Impact of the M22-IPL Acne Filter on Acne Vulgaris
A NA study, sponsored by Lumenis Be.
- Terminated
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT02180282 is a NA study that was terminated before completion, run by Lumenis Be. The registered enrollment target is 13 participants.
The verdict
NCT02180282, a NA study, was terminated before completion, sponsored by Lumenis Be.
- TERMINATED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
Up to 20 healthy subjects age 15-45 years old ,Skin Phototype I-V,Study will be conducted in 1 site. Primary objectives is to evaluate the efficacy of IPL acne filter treatment for improvement of acne vulgaris as assessed by lesion count. .
Interventions
- DEVICE M22-IPL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02180282
The ClinicalTrials.gov registry entry for NCT02180282 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lumenis Be, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which M22-IPL is the first listed.
NCT02180282 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02180282 about?
NCT02180282 is a clinical study titled "Impact of the M22-IPL Acne Filter on Acne Vulgaris". Up to 20 healthy subjects age 15-45 years old ,Skin Phototype I-V,Study will be conducted in 1 site. Primary objectives is to evaluate the efficacy of IPL acne filter treatment for improvement of acne vulgaris as assessed by lesion count. .
What is the current status of trial NCT02180282?
This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2014-07. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02180282?
The interventions under investigation include: M22-IPL (DEVICE).
Who is sponsoring clinical trial NCT02180282?
This trial is sponsored by Lumenis Be, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.